Understanding how the Hepatitis B virus enters and infects liver cells
Viral and Host Determinants of Endosomal Trafficking during HBV Infection
This study is looking at how the Hepatitis B virus gets into liver cells and starts an infection, with the hope of finding new ways to treat chronic HBV infection that could help patients feel better.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Pennsylvania State Univ Hershey Med Ctr NIH-funded |
| Lab location | 1 site (Hershey, United States) |
| Project ID | NIH-10873343 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which the Hepatitis B virus (HBV) enters liver cells and establishes infection. It focuses on the role of the viral capsid in the trafficking process within cells, which is crucial for the production of viral DNA. By studying different HBV capsid mutants, the research aims to identify specific steps in the viral entry process that could be targeted for new treatments. Patients may benefit from insights gained that could lead to more effective therapies for chronic HBV infection.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who are chronically infected with Hepatitis B virus and are experiencing liver-related health issues.
Not a fit: Patients who are not infected with Hepatitis B virus or those who have already been cured of the infection may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies that effectively eliminate Hepatitis B virus from infected individuals.
How similar studies have performed: Previous research has shown promise in understanding viral entry mechanisms, suggesting that this approach could yield valuable insights into HBV infection.
Where this research is happening
Hershey, United States
- Pennsylvania State Univ Hershey Med Ctr — Hershey, United States (Active)
Researchers
- Principal investigator: Mcginley, Megan — Pennsylvania State Univ Hershey Med Ctr
- Study coordinator: Mcginley, Megan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.